BioMap entered a strategic collaboration with Sanofi to co-develop AI modules for biotherapeutic drug discovery leveraging BioMap’s AI platform. BioMap will receive an upfront payment and near-term payments for reaching module development milestones. BioMap is eligible to receive payments of more than $1 billion based on achievement of preclinical development, clinical development, regulatory, and commercial milestones.   Leveraging BioMap’s custom-built foundational models and AI expertise, a...